البحث عن طبيب

Bassam G. Abu Jawdeh, M.D.

  1. Transplant Nephrologist

المنشورات

  1. Mansour E, Boddu SP, Gill VS, Abu Jawdeh BG, McGary AK, Clarke HD, Spangehl MJ, Abdel MP, Ledford CK, Bingham JS. Risk Factors in Patients Who Had Prior Renal or Liver Transplant Undergoing Primary Total Knee Arthroplasty. J Arthroplasty. 2023 Dec 2 Epub 2023 Dec 02
    View PubMed
  2. Abu Jawdeh BG, Smith ML, Hudson MR, Mour GK, Budhiraja P, Rosenthal JL. Case report: JC polyomavirus nephropathy in simultaneous heart-kidney transplantation: the role of viral-specific in situ hybridization staining. Front Med (Lausanne). 2023; 10:1282827 Epub 2023 Oct 20
    View PubMed
  3. Khan D, Zhang N, Abu Jawdeh BG, Swaminathan S, Nair S, Keddis MT. Characteristics and Graft Outcomes of Kidney Transplant Candidates with Enteric Risk Factors and Elevated Plasma Oxalate Levels. Am J Nephrol. 2023; 54 (1-2):42-49 Epub 2023 Feb 13
    View PubMed
  4. Abu Jawdeh BG, Campos-Naciff B, Meganathan K, Steve Woodle E, Dixon BP. The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts. Transplant Direct. 2022 Sep; 8 (9):e1366 Epub 2022 Aug 04
    View PubMed
  5. Abu Jawdeh BG, Nguyen MC, Ryan MS, Vikram HR. Case report: Emphysematous pyelonephritis associated with kidney allograft abscess formation. Front Med (Lausanne). 2022; 9:1066512 Epub 2022 Dec 22
    View PubMed
  6. Lichvar AB, Tremblay S, Leino AD, Shields AR, Cardi MA, Abu Jawdeh BG, Govil A, Kremer J, Cuffy M, Paterno F, Diwan T, Brailey P, Girnita A, Alloway RR, Woodle ES. Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection. Transplantation. 2020 Nov; 104(11):2403-2414.
    View PubMed
  7. Abu Jawdeh BG. COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges. Adv Chronic Kidney Dis. 2020 Sep; 27 (5):383-389 Epub 2020 July 17
    View PubMed
  8. Gudsoorkar P, Anand M, Abu Jawdeh BG. APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness. Am J Nephrol. 2020; 51 (2):116-118 Epub 2020 Jan 15
    View PubMed
  9. Kamal M, Govil A, Anand M, Abu Jawdeh BG, Shah S. Severe BK polyomavirus-induced hemorrhagic cystitis in a kidney transplant recipient with the absence of renal allograft involvement. Transpl Infect Dis. 2018 Feb; 20 (1) Epub 2018 Jan 16
    View PubMed
  10. Abu Jawdeh BG, Woodle ES, Leino AD, Brailey P, Tremblay S, Dorst T, Abdallah MH, Govil A, Byczkowski D, Misra H, Abuchowski A, Alloway RR. A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. Clin Transplant. 2018 Jan; 32 (1) Epub 2017 Dec 04
    View PubMed
  11. Kamal M, Apewokin S, Anand M, Abu Jawdeh BG, Govil A, Sheikh MM, Shah S. Late-Onset Allograft Aspergillosis in an HIV-Positive Renal Transplant Recipient: A Case Report. Transplant Proc. 2017 Sep; 49 (7):1570-1573
    View PubMed
  12. Abu Jawdeh BG, Govil A. Acute Kidney Injury in Transplant Setting: Differential Diagnosis and Impact on Health and Health Care. Adv Chronic Kidney Dis. 2017 Jul; 24 (4):228-232
    View PubMed
  13. Dedhia P, Govil A, Mogilishetty G, Alloway RR, Woodle ES, Abu Jawdeh BG. Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report. Transplant Proc. 2017 Jan - Feb; 49 (1):188-192
    View PubMed
  14. Abu Jawdeh BG, Leonard AC, Sharma Y, Katipally S, Shields AR, Alloway RR, Woodle ES, Thakar CV. Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience. Front Med (Lausanne). 2017; 4:64 Epub 2017 May 26
    View PubMed
  15. Krisl JC, Alloway RR, Shield AR, Govil A, Mogilishetty G, Cardi M, Diwan T, Abu Jawdeh BG, Girnita A, Witte D, Woodle ES. Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival. Transplantation. 2015 Oct; 99(10):2167-73.
    View PubMed
  16. Mittal T, Dedhia P, Abu Jawdeh BG, Mogilishetty G, Roy-Chaudhury P, Cuffy MV, Alloway RR, Woolde ES, Govil A. Complete remission of post-transplant recurrence of focal segmental glomerulosclerosis with adrenocorticotrophic hormone gel: A case report. Transplant Proc. 2015 Sep; 47(7):2219-22.
  17. Revollo JY, Cuffy MC, Abu Jawdeh BG, Woodle ES, Alloway RR. Successful Desensitization and Treatment of Antibody-Mediated Rejection of a Kidney Transplant Recipient Using a Bortezomib-Based Protocol. Transplant Proc. 2015 Sep; 47(7):2254-7.
  18. Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy. Transplantation. 2015 Aug; 99 (8):1691-9
    View PubMed
  19. Woodle ES, Shields AR, Ejaz NS, Sadaka B, Girnita A, Walsh RC, Alloway RR, Brailey P, Cardi MA, Abu Jawdeh BG, Roy-Chaudhury P, Govil A, Mogilishetty G. Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant. 2015 Jan; 15 (1):101-18
    View PubMed
  20. Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation. 2014 Jun 27; 97 (12):1240-6
    View PubMed
  21. Abu Jawdeh BG, Cuffy MC, Alloway RR, Shields AR, Woodle ES. Desensitization in kidney transplantation: review and future perspectives. Clin Transplant. 2014 Apr; 28 (4):494-507 Epub 2014 Mar 12
    View PubMed
  22. Khan S, Abu Jawdeh BG, Goel M, Schilling WP, Parker MD, Puchowicz MA, Yadav SP, Harris RC, El-Meanawy A, Hoshi M, Shinlapawittayatorn K, Deschenes I, Ficker E, Schelling JR. Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. J Clin Invest. 2014 Mar; 124 (3):1057-68 Epub 2014 Feb 17
    View PubMed
  23. Abu Jawdeh BG, Khan S, Deschenes I, Hoshi M, Goel M, Lock JT, Shinlapawittayatorn K, Babcock G, Lakhe-Reddy S, DeCaro G, Yadav SP, Mohan ML, Naga Prasad SV, Schilling WP, Ficker E, Schelling JR. Phosphoinositide binding differentially regulates NHE1 Na+/H+ exchanger-dependent proximal tubule cell survival. J Biol Chem. 2011 Dec 9; 286 (49):42435-42445 Epub 2011 Oct 21
    View PubMed
  24. Abu Jawdeh BG, Rabb H. Delayed kidney allograft function - what does it tell us about acute kidney injury? Contrib Nephrol. 2011; 174:173-181 Epub 2011 Sept 09
    View PubMed
  25. Abu Jawdeh BG, Rahman M. Blood pressure level and kidney disease progression: do we really need to go to 130/80 mm Hg? Curr Hypertens Rep. 2009 Oct; 11 (5):363-7
    View PubMed
  26. Abu Jawdeh BG, Kanso AA, Schelling JR. Evidence-based approach for prevention of radiocontrast-induced nephropathy. J Hosp Med. 2009 Oct; 4 (8):500-6
    View PubMed
  27. Schelling JR, Abu Jawdeh BG. Regulation of cell survival by Na+/H+ exchanger-1. Am J Physiol Renal Physiol. 2008 Sep; 295 (3):F625-32 Epub 2008 May 14
    View PubMed
  28. Khan S, Wu KL, Sedor JR, Abu Jawdeh BG, Schelling JR. The NHE1 Na+/H+ exchanger regulates cell survival by activating and targeting ezrin to specific plasma membrane domains. Cell Mol Biol (Noisy-le-grand). 2006 Dec 30; 52 (8):115-21
    View PubMed
  29. Abu Jawdeh BG. Cryptorchidism: An Update. AUB Surgery. 2002 Jul; 1(3 (Summer 02)):11-16.